{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:36Z","timestamp":1707525396228},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,22]]},"DOI":"10.7759\/cureus.47494","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T05:21:21Z","timestamp":1698038481000},"source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial Susceptibility Trends of Proteeae Isolates From a Tertiary-Care Hospital in Western Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Rania A","family":"El-Kady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samah A","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taef  T","family":"Aljabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razan  R","family":"Haraka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imtinan  M","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal  I","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayar  W","family":"Bashbeshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.4.534","article-title":"Classification, identification, and clinical significance of Proteus, Providencia, and Morganella","volume":"13","author":"O'Hara CM","year":"2000","unstructured":"O'Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev. 2000, 13:534-46. 10.1128\/CMR.13.4.534","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000445426","article-title":"Characterization of integrons and qnr genes in Proteeae from a teaching hospital in China","volume":"62","author":"Cao J","year":"2017","unstructured":"Cao J, Li M, Xu C, et al.. Characterization of integrons and qnr genes in Proteeae from a teaching hospital in China. Chemotherapy. 2017, 62:12-8. 10.1159\/000445426","journal-title":"Chemotherapy"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8030091","article-title":"Comparative epidemiology and resistance trends of proteae in urinary tract infections of inpatients and outpatients: a 10-year retrospective study","volume":"8","author":"Gajd\u00e1cs M","year":"2019","unstructured":"Gajd\u00e1cs M, Urb\u00e1n E. Comparative epidemiology and resistance trends of proteae in urinary tract infections of inpatients and outpatients: a 10-year retrospective study. Antibiotics (Basel). 2019, 8:10.3390\/antibiotics8030091","journal-title":"Antibiotics (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-020-02372-w","article-title":"Association among biofilm formation, virulence gene expression, and antibiotic resistance in Proteus mirabilis isolates from diarrhetic animals in Northeast China","volume":"16","author":"Sun Y","year":"2020","unstructured":"Sun Y, Wen S, Zhao L, et al.. Association among biofilm formation, virulence gene expression, and antibiotic resistance in Proteus mirabilis isolates from diarrhetic animals in Northeast China. BMC Vet Res. 2020, 16:176. 10.1186\/s12917-020-02372-w","journal-title":"BMC Vet Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s42770-020-00240-1","article-title":"Proteus mirabilis causing cellulitis in broiler chickens","volume":"51","author":"Sanches MS","year":"2020","unstructured":"Sanches MS, Baptista AA, de Souza M, et al.. Proteus mirabilis causing cellulitis in broiler chickens. Braz J Microbiol. 2020, 51:1353-62. 10.1007\/s42770-020-00240-1","journal-title":"Braz J Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.07.006","article-title":"Morganella morganii, a non-negligent opportunistic pathogen","volume":"50","author":"Liu H","year":"2016","unstructured":"Liu H, Zhu J, Hu Q, Rao X. Morganella morganii, a non-negligent opportunistic pathogen. Int J Infect Dis. 2016, 50:10-7. 10.1016\/j.ijid.2016.07.006","journal-title":"Int J Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-24163","article-title":"Providencia causing urinary tract infections: are we reaching a dead end?","volume":"26","author":"Rajni E","year":"2022","unstructured":"Rajni E, Jain A, Garg VK, Sharma R, Vohra R, Jain SS. Providencia causing urinary tract infections: are we reaching a dead end?. Indian J Crit Care Med. 2022, 26:446-51. 10.5005\/jp-journals-10071-24163","journal-title":"Indian J Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.04.011","article-title":"Antimicrobial susceptibility and distribution of extended-spectrum \u03b2-lactamases, AmpC \u03b2-lactamases and carbapenemases among Proteus, Providencia and Morganella isolated from global hospitalised patients with intra-abdominal and urinary tract infections: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2008-2011","volume":"22","author":"Yang JH","year":"2020","unstructured":"Yang JH, Sheng WH, Hsueh PR. Antimicrobial susceptibility and distribution of extended-spectrum \u03b2-lactamases, AmpC \u03b2-lactamases and carbapenemases among Proteus, Providencia and Morganella isolated from global hospitalised patients with intra-abdominal and urinary tract infections: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2008-2011. J Glob Antimicrob Resist. 2020, 22:398-407. 10.1016\/j.jgar.2020.04.011","journal-title":"J Glob Antimicrob Resist"},{"key":"ref9","unstructured":"Performance Standards for Antimicrobial Susceptibility Testing, M100, 29th ed. (2019). https.\/\/clsi.org\/media\/2663\/m100ed29_sample.pdf."},{"key":"ref10","unstructured":"Performance Standards for Antimicrobial Susceptibility Testing, M100, 30th ed. (2019). https.\/\/clsi.org\/media\/3481\/m100ed30_sample.pdf."},{"key":"ref11","unstructured":"EUCAST European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 9.0. (2019). Accessed. 19 November 2020: http:\/\/www.eucast.org."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos AP","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al.. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012, 18:268-81. 10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2440-7","article-title":"Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit","volume":"17","author":"Axente C","year":"2017","unstructured":"Axente C, Licker M, Moldovan R, et al.. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit. BMC Infect Dis. 2017, 17:358. 10.1186\/s12879-017-2440-7","journal-title":"BMC Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01715.x","article-title":"Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region","volume":"13","author":"Laupland KB","year":"2007","unstructured":"Laupland KB, Parkins MD, Ross T, Pitout JD. Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region. Clin Microbiol Infect. 2007, 13:683-8. 10.1111\/j.1469-0691.2007.01715.x","journal-title":"Clin Microbiol Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/0036554021000027015","article-title":"Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000)","volume":"35","author":"Kim BN","year":"2003","unstructured":"Kim BN, Kim NJ, Kim MN, Kim YS, Woo JH, Ryu J. Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000). Scand J Infect Dis. 2003, 35:98-103. 10.1080\/0036554021000027015","journal-title":"Scand J Infect Dis"},{"key":"ref16","article-title":"The genera Proteus, Providencia, and Morganella","author":"Manos J","unstructured":"Manos J, Belas R. The genera Proteus, Providencia, and Morganella. The Prokaryotes: Volume 6: Proteobacteria: Gamma Subclass. Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrandt E (ed): Springer, New York; 6:245-69."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1231807","article-title":"Assessment of pathogenic potential, virulent genes profile, and antibiotic susceptibility of Proteus mirabilis from urinary tract infection","volume":"2020","author":"Hussein EI","year":"2020","unstructured":"Hussein EI, Al-Batayneh K, Masadeh MM, Dahadhah FW, Al Zoubi MS, Aljabali AA, Alzoubi KH. Assessment of pathogenic potential, virulent genes profile, and antibiotic susceptibility of Proteus mirabilis from urinary tract infection. Int J Microbiol. 2020, 2020:1231807. 10.1155\/2020\/1231807","journal-title":"Int J Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v17i2.9","article-title":"Molecular screening of antibiotic-resistant determinants among multidrug-resistant clinical isolates of Proteus mirabilis from SouthWest Nigeria","volume":"17","author":"Alabi OS","year":"2017","unstructured":"Alabi OS, Mendon\u00e7a N, Adeleke OE, da Silva GJ. Molecular screening of antibiotic-resistant determinants among multidrug-resistant clinical isolates of Proteus mirabilis from SouthWest Nigeria. Afr Health Sci. 2017, 17:356-65. 10.4314\/ahs.v17i2.9","journal-title":"Afr Health Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/NJM.NJM_39_22","article-title":"Detection of extended-spectrum beta-lactamase genes in members of the Proteeae tribe isolated from a tertiary hospital in Southeast, Nigeria","volume":"31","author":"Akujobi CN","year":"2022","unstructured":"Akujobi CN, Okwesilieze CV, Aghanya IN, et al.. Detection of extended-spectrum beta-lactamase genes in members of the Proteeae tribe isolated from a tertiary hospital in Southeast, Nigeria. Niger J Med. 2022, 31:429-34. 10.4103\/NJM.NJM_39_22","journal-title":"Niger J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-022-02662-3","article-title":"Prevalence of extended-spectrum \u03b2-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates","volume":"22","author":"Shaaban M","year":"2022","unstructured":"Shaaban M, Elshaer SL, Abd El-Rahman OA. Prevalence of extended-spectrum \u03b2-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates. BMC Microbiol. 2022, 22:247. 10.1186\/s12866-022-02662-3","journal-title":"BMC Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh047","article-title":"ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital","volume":"53","author":"Tumbarello M","year":"2004","unstructured":"Tumbarello M, Citton R, Spanu T, Sanguinetti M, Romano L, Fadda G, Cauda R. ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. J Antimicrob Chemother. 2004, 53:277-82. 10.1093\/jac\/dkh047","journal-title":"J Antimicrob Chemother"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S280977","article-title":"Distribution of NDM1 carbapenemase-producing Proteeae strains on high-risk hospital wards","volume":"13","author":"Rus M","year":"2020","unstructured":"Rus M, Licker M, Musuroi C, et al.. Distribution of NDM1 carbapenemase-producing Proteeae strains on high-risk hospital wards. Infect Drug Resist. 2020, 13:4751-61. 10.2147\/IDR.S280977","journal-title":"Infect Drug Resist"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2022.43.8.20220238","article-title":"The prevalence of multiple drug resistant urinary tract infections: a single-centered, observational retrospective study in King Abdulaziz Specialized Hospital, Taif, Saudi Arabia","volume":"43","author":"Alhomayani FK","year":"2022","unstructured":"Alhomayani FK, Alazwari NM, Alshhrani MS, et al.. The prevalence of multiple drug resistant urinary tract infections: a single-centered, observational retrospective study in King Abdulaziz Specialized Hospital, Taif, Saudi Arabia. Saudi Med J. 2022, 43:927-32. 10.15537\/smj.2022.43.8.20220238","journal-title":"Saudi Med J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00569-22","article-title":"Morganella morganii, an emerging cause of bloodstream infections","volume":"10","author":"Laupland KB","year":"2022","unstructured":"Laupland KB, Paterson DL, Edwards F, Stewart AG, Harris PN. Morganella morganii, an emerging cause of bloodstream infections. Microbiol Spectr. 2022, 10:e0056922. 10.1128\/spectrum.00569-22","journal-title":"Microbiol Spectr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2023.115945","article-title":"Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018-2022)","volume":"106","author":"Sader HS","year":"2023","unstructured":"Sader HS, Mendes RE, Duncan L, Kimbrough JH, Carvalhaes CG, Castanheira M. Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018-2022). Diagn Microbiol Infect Dis. 2023, 106:115945. 10.1016\/j.diagmicrobio.2023.115945","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-018-0272-y","article-title":"Emergence of multidrug-resistant Providencia rettgeri isolates co-producing NDM-1 carbapenemase and PER-1 extended-spectrum \u03b2-lactamase causing a first outbreak in Korea","volume":"17","author":"Shin S","year":"2018","unstructured":"Shin S, Jeong SH, Lee H, Hong JS, Park MJ, Song W. Emergence of multidrug-resistant Providencia rettgeri isolates co-producing NDM-1 carbapenemase and PER-1 extended-spectrum \u03b2-lactamase causing a first outbreak in Korea. Ann Clin Microbiol Antimicrob. 2018, 17:20. 10.1186\/s12941-018-0272-y","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-019-1208-x","article-title":"Risk factors of health care-associated infection in elderly patients: a retrospective cohort study performed at a tertiary hospital in China","volume":"19","author":"Zhao X","year":"2019","unstructured":"Zhao X, Wang L, Wei N, Zhang J, Ma W, Zhao H, Han X. Risk factors of health care-associated infection in elderly patients: a retrospective cohort study performed at a tertiary hospital in China. BMC Geriatr. 2019, 19:193. 10.1186\/s12877-019-1208-x","journal-title":"BMC Geriatr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58020271","article-title":"Association of Proteus mirabilis and Providencia stuartii infections with diabetes","volume":"58","author":"Rus M","year":"2022","unstructured":"Rus M, Licker M, Musuroi C, et al.. Association of Proteus mirabilis and Providencia stuartii infections with diabetes. Medicina (Kaunas). 2022, 58:10.3390\/medicina58020271","journal-title":"Medicina (Kaunas)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2018.09.007","article-title":"First report of carbapenem-resistant Providencia stuartii in Saudi Arabia","volume":"26","author":"Abdallah M","year":"2018","unstructured":"Abdallah M, Alhababi R, Alqudah N, Aldyyat B, Alharthy A. First report of carbapenem-resistant Providencia stuartii in Saudi Arabia. New Microbes New Infect. 2018, 26:107-9. 10.1016\/j.nmni.2018.09.007","journal-title":"New Microbes New Infect"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2017.08.021","article-title":"Risk factors for infection with multidrug-resistant organisms in Haryana, India","volume":"46","author":"Kalluru S","year":"2018","unstructured":"Kalluru S, Eggers S, Barker A, et al.. Risk factors for infection with multidrug-resistant organisms in Haryana, India. Am J Infect Control. 2018, 46:341-5. 10.1016\/j.ajic.2017.08.021","journal-title":"Am J Infect Control"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/197363-antimicrobial-susceptibility-trends-of-proteeae-isolates-from-a-tertiary-care-hospital-in-western-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:17Z","timestamp":1707509237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/197363-antimicrobial-susceptibility-trends-of-proteeae-isolates-from-a-tertiary-care-hospital-in-western-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,22]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.47494","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,22]]}}}